Topical Treatment of Under Eye Dark Circles and Swelling
Information source: The Connecticut Sinus Center, PC
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Edema
Intervention: Fexofenadine (Drug); Placebo (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: The Connecticut Sinus Center, PC Official(s) and/or principal investigator(s): Edward M Lane, MD, Study Director, Affiliation: The Connecticut Sinus Center, PC
Summary
This study examines topical treatment of under eye circles and swelling.
Clinical Details
Official title: A Pilot Randomized Double Blind Study to Assess the Safety and Efficacy of 1% Ibuprofen/ 1%Fexofenadine Topical Cream for the Treatment of Dark Circles Under the Eyes
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Primary outcome: Number of Participants Who Showed Improvement in Under Eye Swelling and Dark Circles Relative to Baseline Per Intervention
Detailed description:
This study examines topical treatment of under eyes dark circles and under eye swelling.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Under eye dark circles and swelling
Exclusion Criteria:
- Under age 18
- Allergy to tested medicines
Locations and Contacts
TKL Research, Paramus, New Jersey 07652, United States
Additional Information
Starting date: September 2010
Last updated: February 16, 2015
|